Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review
Lung cancer is the most common and deadliest cancer type globally. Its early diagnosis can guarantee a five-year survival rate. Unfortunately, application of the available diagnosis methods such as computed tomography, chest radiograph, magnetic resonance imaging (MRI), ultrasound, low-dose CT scan,...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1c03a2d5aca74cbd8866942f25882066 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1c03a2d5aca74cbd8866942f25882066 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1c03a2d5aca74cbd8866942f258820662021-11-25T17:13:44ZPlasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review10.3390/chemosensors91103262227-9040https://doaj.org/article/1c03a2d5aca74cbd8866942f258820662021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9040/9/11/326https://doaj.org/toc/2227-9040Lung cancer is the most common and deadliest cancer type globally. Its early diagnosis can guarantee a five-year survival rate. Unfortunately, application of the available diagnosis methods such as computed tomography, chest radiograph, magnetic resonance imaging (MRI), ultrasound, low-dose CT scan, bone scans, positron emission tomography (PET), and biopsy is hindered due to one or more problems, such as phenotypic properties of tumours that prevent early detection, invasiveness, expensiveness, and time consumption. Detection of lung cancer biomarkers using a biosensor is reported to solve the problems. Among biosensors, optical biosensors attract greater attention due to being ultra-sensitive, free from electromagnetic interference, capable of wide dynamic range detection, free from the requirement of a reference electrode, free from electrical hazards, highly stable, capable of multiplexing detection, and having the potential for more information content than electrical transducers. Inspired by promising features of plasmonic sensors, including surface plasmon resonance (SPR), localised surface plasmon resonance (LSPR), and surface enhanced Raman scattering (SERS) such as ultra-sensitivity, single particle/molecular level detection capability, multiplexing capability, photostability, real-time measurement, label-free measurement, room temperature operation, naked-eye readability, and the ease of miniaturisation without sophisticated sensor chip fabrication and instrumentation, numerous plasmonic sensors for the detection of lung cancer biomarkers have been investigated. In this review, the principle plasmonic sensor is explained. In addition, novel strategies and modifications adopted for the detection of lung cancer biomarkers such as miRNA, carcinoembryonic antigen (CEA), cytokeratins, and volatile organic compounds (VOCs) using plasmonic sensors are also reported. Furthermore, the challenges and prospects of the plasmonic biosensors for the detection of lung cancer biomarkers are highlighted.Fahad UsmanJohn Ojur DennisA.I. AljameelM.K.M. AliO. AldaghriK.H. IbnaoufZakariyya Uba ZangoMahnoush BeygisangchinAhmed AlsadigFabrice MeriaudeauMDPI AGarticleplasmonic biosensorslung cancerbiomarkerssurface plasmon resonancesurface enhanced Raman scatteringlocalised surface plasmon resonanceBiochemistryQD415-436ENChemosensors, Vol 9, Iss 326, p 326 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
plasmonic biosensors lung cancer biomarkers surface plasmon resonance surface enhanced Raman scattering localised surface plasmon resonance Biochemistry QD415-436 |
spellingShingle |
plasmonic biosensors lung cancer biomarkers surface plasmon resonance surface enhanced Raman scattering localised surface plasmon resonance Biochemistry QD415-436 Fahad Usman John Ojur Dennis A.I. Aljameel M.K.M. Ali O. Aldaghri K.H. Ibnaouf Zakariyya Uba Zango Mahnoush Beygisangchin Ahmed Alsadig Fabrice Meriaudeau Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review |
description |
Lung cancer is the most common and deadliest cancer type globally. Its early diagnosis can guarantee a five-year survival rate. Unfortunately, application of the available diagnosis methods such as computed tomography, chest radiograph, magnetic resonance imaging (MRI), ultrasound, low-dose CT scan, bone scans, positron emission tomography (PET), and biopsy is hindered due to one or more problems, such as phenotypic properties of tumours that prevent early detection, invasiveness, expensiveness, and time consumption. Detection of lung cancer biomarkers using a biosensor is reported to solve the problems. Among biosensors, optical biosensors attract greater attention due to being ultra-sensitive, free from electromagnetic interference, capable of wide dynamic range detection, free from the requirement of a reference electrode, free from electrical hazards, highly stable, capable of multiplexing detection, and having the potential for more information content than electrical transducers. Inspired by promising features of plasmonic sensors, including surface plasmon resonance (SPR), localised surface plasmon resonance (LSPR), and surface enhanced Raman scattering (SERS) such as ultra-sensitivity, single particle/molecular level detection capability, multiplexing capability, photostability, real-time measurement, label-free measurement, room temperature operation, naked-eye readability, and the ease of miniaturisation without sophisticated sensor chip fabrication and instrumentation, numerous plasmonic sensors for the detection of lung cancer biomarkers have been investigated. In this review, the principle plasmonic sensor is explained. In addition, novel strategies and modifications adopted for the detection of lung cancer biomarkers such as miRNA, carcinoembryonic antigen (CEA), cytokeratins, and volatile organic compounds (VOCs) using plasmonic sensors are also reported. Furthermore, the challenges and prospects of the plasmonic biosensors for the detection of lung cancer biomarkers are highlighted. |
format |
article |
author |
Fahad Usman John Ojur Dennis A.I. Aljameel M.K.M. Ali O. Aldaghri K.H. Ibnaouf Zakariyya Uba Zango Mahnoush Beygisangchin Ahmed Alsadig Fabrice Meriaudeau |
author_facet |
Fahad Usman John Ojur Dennis A.I. Aljameel M.K.M. Ali O. Aldaghri K.H. Ibnaouf Zakariyya Uba Zango Mahnoush Beygisangchin Ahmed Alsadig Fabrice Meriaudeau |
author_sort |
Fahad Usman |
title |
Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review |
title_short |
Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review |
title_full |
Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review |
title_fullStr |
Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review |
title_full_unstemmed |
Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review |
title_sort |
plasmonic biosensors for the detection of lung cancer biomarkers: a review |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/1c03a2d5aca74cbd8866942f25882066 |
work_keys_str_mv |
AT fahadusman plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview AT johnojurdennis plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview AT aialjameel plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview AT mkmali plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview AT oaldaghri plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview AT khibnaouf plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview AT zakariyyaubazango plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview AT mahnoushbeygisangchin plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview AT ahmedalsadig plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview AT fabricemeriaudeau plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview |
_version_ |
1718412574895112192 |